Tumor-targeting peptides from combinatorial libraries

Ruiwu Liu, Xiaocen Li, Wenwu Xiao, Kit Lam

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Cancer is one of the major and leading causes of death worldwide. Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or minimum side effects. Widespread use of targeted therapies and molecular imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites. Combinatorial libraries such as phage-display and one-bead one-compound (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides. This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides. Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed. Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.

Original languageEnglish (US)
JournalAdvanced Drug Delivery Reviews
DOIs
StateAccepted/In press - Mar 19 2016

Fingerprint

Peptide Library
Neoplasms
Peptides
Molecular Imaging
Early Detection of Cancer
Bacteriophages
Cause of Death
Ligands
Technology
Therapeutics

Keywords

  • Biological library
  • Cell surface receptor
  • High throughput screening
  • One-bead one-compound peptide library
  • Phage-display peptide library
  • Tumor-targeting peptide

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Tumor-targeting peptides from combinatorial libraries. / Liu, Ruiwu; Li, Xiaocen; Xiao, Wenwu; Lam, Kit.

In: Advanced Drug Delivery Reviews, 19.03.2016.

Research output: Contribution to journalArticle

@article{ef0093c59d38463ca8317abf2eb87992,
title = "Tumor-targeting peptides from combinatorial libraries",
abstract = "Cancer is one of the major and leading causes of death worldwide. Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or minimum side effects. Widespread use of targeted therapies and molecular imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites. Combinatorial libraries such as phage-display and one-bead one-compound (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides. This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides. Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed. Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.",
keywords = "Biological library, Cell surface receptor, High throughput screening, One-bead one-compound peptide library, Phage-display peptide library, Tumor-targeting peptide",
author = "Ruiwu Liu and Xiaocen Li and Wenwu Xiao and Kit Lam",
year = "2016",
month = "3",
day = "19",
doi = "10.1016/j.addr.2016.05.009",
language = "English (US)",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Tumor-targeting peptides from combinatorial libraries

AU - Liu, Ruiwu

AU - Li, Xiaocen

AU - Xiao, Wenwu

AU - Lam, Kit

PY - 2016/3/19

Y1 - 2016/3/19

N2 - Cancer is one of the major and leading causes of death worldwide. Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or minimum side effects. Widespread use of targeted therapies and molecular imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites. Combinatorial libraries such as phage-display and one-bead one-compound (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides. This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides. Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed. Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.

AB - Cancer is one of the major and leading causes of death worldwide. Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or minimum side effects. Widespread use of targeted therapies and molecular imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites. Combinatorial libraries such as phage-display and one-bead one-compound (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides. This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides. Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed. Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.

KW - Biological library

KW - Cell surface receptor

KW - High throughput screening

KW - One-bead one-compound peptide library

KW - Phage-display peptide library

KW - Tumor-targeting peptide

UR - http://www.scopus.com/inward/record.url?scp=85006414950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006414950&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2016.05.009

DO - 10.1016/j.addr.2016.05.009

M3 - Article

C2 - 27210583

AN - SCOPUS:85006414950

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -